Compare Biosino Bio-Technology & Science, Inc. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-44.55%
0%
-44.55%
6 Months
129.01%
0%
129.01%
1 Year
383.87%
0%
383.87%
2 Years
252.94%
0%
252.94%
3 Years
177.78%
0%
177.78%
4 Years
97.37%
0%
97.37%
5 Years
143.9%
0%
143.9%
Biosino Bio-Technology & Science, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.46%
EBIT Growth (5y)
-1.58%
EBIT to Interest (avg)
9.76
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
1.04
Tax Ratio
24.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.80%
ROE (avg)
4.41%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
4.68
EV to EBIT
41.14
EV to EBITDA
22.52
EV to Capital Employed
3.26
EV to Sales
2.29
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
7.93%
ROE (Latest)
11.65%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
88.20
96.80
-8.88%
Operating Profit (PBDIT) excl Other Income
13.00
-7.90
264.56%
Interest
1.50
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.50
-4.70
344.68%
Operating Profit Margin (Excl OI)
74.80%
-81.10%
15.59%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is -8.88% vs 10.63% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 344.68% vs -173.44% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
199.90
285.20
-29.91%
Operating Profit (PBDIT) excl Other Income
-39.20
-22.80
-71.93%
Interest
7.40
10.10
-26.73%
Exceptional Items
-4.90
-14.10
65.25%
Consolidate Net Profit
-70.50
-61.70
-14.26%
Operating Profit Margin (Excl OI)
-293.00%
-145.00%
-14.80%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -29.91% vs -10.71% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -14.26% vs -189.67% in Dec 2024
About Biosino Bio-Technology & Science, Inc. 
Biosino Bio-Technology & Science, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






